Penny Stock Near the Top of the Nasdaq

The FDA granted Neovasc's Reducer device a breakthrough designation

by Patrick Martin

Published on Oct 10, 2018 at 10:13 AM

Neovasc Inc (NASDAQ:NVCN) is up 35.6%% to trade at $3.31, one of the best stocks on the Nasdaq this morning, after the medical device maker's Reducer was granted breakthrough status by the Food and Drug Administration (FDA). Neovasc's Reducer is an implantation used to treat refractory angina. 

Neovasc stock is now on track for its best day since April 6, though familiar resistance near the $3.30 level is emerging. Plus, NVCN is still staring at a 94% deficit for 2018. 

TapImmune Inc (NASDAQ:TPIV) was up almost 4% earlier on news the biotech's breast cancer vaccine will be studied at the Mayo Clinic. The $11 million grant will be a part of a larger Phase 2 immunotherapy combo study. The shares have since swung down 0.8% to trade at $8.88

Nevertheless, TPIV has more than doubled in 2018, and nearly tripled in value year-over-year. In the past month, the shares consolidated atop double-barreled support at their 32- and 80-day moving averages.

A short squeeze could keep the wind at the drugmaker's back. Short interest increased by 20% in the last two reporting periods to a record high 1.01 million shares. This represents nearly 10% of TPIV's total available float, and four days of pent-up buying power, at the stock's average pace of trading. 
SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.